We're offering Lifetime and discounted 3-year Subscriptions this month only. Details here

Message Boards | Biotechnology : Synta Pharmaceuticals -- Ignore and Intra-subject Search unavailable to you. Want to Upgrade?
Posts: 89 | Member SubjectMarks: 13 | No Bans | Board Shortcut:

Add SubjectMark | Hide Original Post | Show Chart | Poster Summary | Email This Page

Moderated By: WilderElisimo -- (Moderated) -- Started: 2/8/2007 12:38:48 PM  Revision History

Speak. Listen. Contribute.
Previous 10 | Next 10 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplySubjectFromRecsDate
89Synta Presents Preclinical Data on Next Generation Hsp90 Inhibitor, STA-9090Busimopgcw-11/20/2009 09:00:45 PM
88seekingalpha: Synta Pharmaceuticals Corp. (SNTA) mopgcw-11/07/2009 09:37:27 AM
87Anyone know if management has articulated their partnering strategy for STA-9090tuck-08/26/2009 03:35:21 PM
86another chunk of insider buying..mopgcw-08/26/2009 11:46:00 AM
85some large insider purchases here...@ $2.85/sharemopgcw-08/07/2009 03:30:25 PM
84Synta Pharmaceuticals Announces Presentation of Prmopgcw-06/01/2009 04:46:23 PM
83[The novel HSP90 inhibitor STA-9090 exhibits activtuck-03/06/2009 11:32:44 AM
82I meant $3, time to walk. Where is that edit buttkenhott-03/03/2009 10:29:36 AM
81Synta is now a phase I company in a crowded space, what's the appeal of holding rkrw-03/02/2009 02:03:21 PM
80I agreed, and sold it all this morning. as much asmopgcw-03/02/2009 01:17:00 PM
79$2.20. I would walk at this point. Good luck.kenhott-03/02/2009 12:45:48 PM
Previous 10 | Next 10 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):


Copyright © 2009 TZ Holdings LLC. All rights reserved.